News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Diego A. Díaz García Reflects on a Decade of Growth at ASCO25
Diego A. Díaz García/X
Jun 6, 2025, 12:51

Diego A. Díaz García Reflects on a Decade of Growth at ASCO25

Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X:

“10 years ago: a young internal medicine resident attending my first ASCO congress, full of questions and curiosity.
Today: walking the halls not as a learner only, but as a contributor to the science I once admired from afar.
Grateful for the journey, the mentors, and the science. ASCO25 complete. Onward.”

Diego A. Díaz García reflected on his growth from a curious resident at his first ASCO meeting to a contributing scientist at ASCO25, expressing gratitude for the mentors and scientific journey that shaped his path.

Diego A. Díaz García Reflects on a Decade of Growth at ASCO25

More posts featuring Diego A. Díaz García.

ASCO ASCO25 cancer Diego A. Díaz García fight against cancer Global fight against cancer OncoDaily Oncology
Special Coverage
Opinion
Jul 27, 2025, 17:27
Ian Davis: Why Chemotherapy Has Not Stopped Working in Metastatic Prostate Cancer for More than 20 Years
Blog
Jul 27, 2025, 16:53
Luis E. Raez: The FLASCO “Breaking Barriers” Conference Returns This November
Career
Jul 27, 2025, 16:20
Justin Perry Has Been Promoted to Associate Member at Memorial Sloan Kettering Cancer Center
Blog
Jul 27, 2025, 16:04
Helena Linardou: ESMO Virtual Journal Club – July 2025 Edition
Blog
Jul 27, 2025, 15:57
A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 - IASLC
Blog
Jul 27, 2025, 15:38
Sergio Cifuentes Canaval: First Meeting of Young Oncologists Group
Science
Jul 27, 2025, 15:14
Talha Badar: PII Trial of CPX-351 and Venetoclax
Insight
Jul 27, 2025, 15:13
Potential Breakthrough for Glioma: Servier’s Therapy Nears EMA Approval - Servier Pharmaceuticals
Blog
Jul 27, 2025, 15:03
Neil Gross: Giving an Update on the Progress of HN014 C-PRE for Skin CSCC Cancer
Blog
Jul 27, 2025, 14:26
Chadi Nabhan: How to Survive and Thrive in Fellowship?
Blog
Jul 27, 2025, 14:15
Alireza Mansouri: What Does the Clinical Community vs General Public Think of GBM Clinical Trials?
Blog
Jul 27, 2025, 14:04
What Were the Key Takeaways from ASCO25? - IASLC